30
Participants
Start Date
December 31, 2005
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
Atenolol
100 mg tablets orally once a day (od) in the morning.
Hydrochlorothiazide (HCTZ))
12.5 or 25 mg tablets orally once a day (od) in the morning.
Valsartan
80 mg, 160 mg, or 320 mg tablets orally once a day in the morning
Investigative Centers
Novartis Pharma Ag, Basel
Lead Sponsor
Novartis
INDUSTRY